横浜薬科大学 · 健康薬学科

研究キーワード骨粗鬆症治療薬と抗うつ薬の研究

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• 2. Human immunodeficiency virus type 1(HIV-1) reverse transcriptase inhibitory effect of Cymbopogon Nardus essential oil. Kazuya Mori, Etienne Kochole Obosou, Shoutaro Suwa, Shogo Miura, Soon Oh, Natauki Jinbo, Yukiko Ishibashi , Yasuo Shikamoto, Tetsuji Hosono, Takahiro Toda, Koji Tomobe, Tatsuo Shinozuka, Shigeo Nakajo, International Journal of Advanced Research in Botany, Vol.2, Issue 1, 7-13 (2016).2016
• 1. Fluvoxamine reverses estrogen-dependent decline in voluntary activities and decreased amygdala levels of serotonin in ovariectomized rats. Ishibashi Y , Izumo N, Iwata K, Morikawa T, Kameyama T, Watanabe Y, Manabe T, Matsuzaki H, Journal of Brain Science, 46, 5-19, June 30 (2016).2016
• 3. Modulation of osteoblast differentiation and bone mass by 5-HT2A receptor signaling in mice. Tanaka K, Hirai T, Ishibashi Y , Izumo N, Togari A, Eur J Pharmacol., 762, 150-157, Sep 5, (2015).2015
• 4. Fluvoxamine moderates reduced voluntary activity following chronic dexamethasone infusion in mice via recovery of BDNF signal cascades. Terada K, Izumo N, Suzuki B, Karube Y, Morikawa T, Ishibashi Y , Kameyama T, Chiba K, Sasaki N, Iwata K, Matsuzaki H, Manabe T, Neurochem. Int., 69, 9-13 (2014).2014

• 公式プロフィール